Linscomb Wealth Inc. Has $470,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Linscomb Wealth Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 949 shares of the healthcare conglomerate’s stock after selling 29 shares during the quarter. Linscomb Wealth Inc.’s holdings in UnitedHealth Group were worth $470,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Quadrature Capital Ltd acquired a new stake in UnitedHealth Group in the 1st quarter valued at approximately $60,438,000. GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $346,000. Stonebridge Capital Advisors LLC lifted its position in shares of UnitedHealth Group by 8.8% in the 1st quarter. Stonebridge Capital Advisors LLC now owns 26,059 shares of the healthcare conglomerate’s stock worth $12,891,000 after acquiring an additional 2,112 shares during the period. Guardian Capital LP lifted its position in shares of UnitedHealth Group by 0.9% in the 1st quarter. Guardian Capital LP now owns 56,015 shares of the healthcare conglomerate’s stock worth $27,711,000 after acquiring an additional 477 shares during the period. Finally, Westwood Holdings Group Inc. lifted its position in shares of UnitedHealth Group by 8.2% in the 1st quarter. Westwood Holdings Group Inc. now owns 226,326 shares of the healthcare conglomerate’s stock worth $111,964,000 after acquiring an additional 17,170 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.8 %

UNH stock traded up $10.04 during midday trading on Friday, hitting $569.72. 3,202,023 shares of the company’s stock were exchanged, compared to its average volume of 5,159,030. The company has a market cap of $524.36 billion, a PE ratio of 34.82, a price-to-earnings-growth ratio of 1.56 and a beta of 0.60. The stock’s fifty day moving average price is $508.82 and its 200-day moving average price is $501.45. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $581.50. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the company posted $6.14 earnings per share. UnitedHealth Group’s revenue was up 6.4% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

A number of analysts have commented on the company. Robert W. Baird raised their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Barclays raised their target price on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Wells Fargo & Company raised their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Piper Sandler raised their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Finally, HSBC lifted their price objective on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.